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1296 Risk factors of mortality and permanent neurologic injury in patients
undergoing ascending aortic and arch repair
Martin Czerny, MD, Tatjana Fleck, MD, Daniel Zimpfer, MD, Martin Dworschak, MD,
Wolfgang Hofmann, MD, Doris Hutschala, MD, Daniela Dunkler, MSc, Marek Ehrlich, MD,
Ernst Wolner, MD, and Martin Grabenwoger, MD, Vienna, Austria
Outcome in elderly patients after surgical repair of the ascending aorta and the aortic arch as
compared with their younger counterparts was analyzed. Age showed a trend toward a higher
risk of mortality. DHCA but not age predicted a higher incidence of permanent neurologic
injury.
1302 In situ retrocaval skeletonized right internal thoracic artery anastomosed to
the circumflex system via transverse sinus: Technical aspects and
postoperative outcome
Massimo Bonacchi, MD, Edvin Prifti, MD, PhD, Francesco Battaglia, MD,
Giacomo Frati, MD, Guido Sani, MD, and Georges Popoff, MD, Firenze, Italy
The most distal branch of the circumflex system could be grafted with in situ skeletonized
RITA routed via the transverse sinus and eventually behind the superior caval vein with an
excellent postoperative patency rate. The presence of diabetes, severe obesity, a small body,
female sex, older age, and left ventricular dysfunction seem not to represent critical
contraindications for such a strategy.
1314 Skeletonization of bilateral internal thoracic artery grafts lowers the risk of
sternal infection in patients with diabetes
Mark D. Peterson, MD, Michael A. Borger, MD, PhD, Vivek Rao, MD, PhD,
Charles M. Peniston, MD, and Christopher M. Feindel, MD, Toronto, Ontario, Canada
We demonstrate that skeletonization of bilateral internal thoracic artery conduits results in a
significantly lower prevalence of deep sternal wound infection compared with pedicled conduits
in patients with diabetes. Skeletonization allows bilateral internal thoracic artery grafting to be
safely performed in patients with diabetes.
1320 Survival after myocardial revascularization for ischemic cardiomyopathy:
A prospective ten-year follow-up study
Pallav J. Shah, MBBS, MS, McH, David L. Hare, MBBS, DPM, FRACP, Jai S. Raman, MBBS,
MMed, FRACS, PhD, Ian Gordon, MSc, PhD, AStat, Robert K. Chan, MBBS, PhD, FRACP,
John D. Horowitz, MBBS, PhD, FRACP, Alex Rosalion, MBBS, FRACS, and Brian F. Buxton,
MB, MS, FRACS, FRCS, FRCS(C), Melbourne, Victoria, and Adelaide, South Australia,
Australia
This study prospectively analyzed all-cause mortality and the predictors of 10-year survival in
57 patients undergoing surgical myocardial revascularization for ischemic cardiomyopathy
(LVEF  35% on radionuclide ventriculography). Patients with stunned myocardium were
specifically excluded from the study. Although there was symptomatic and functional
improvement, there was no significant improvement in the mean LVEF postoperatively.
Survival was 82.5% at 1 year, 55.7% at 5 years, and 23.9% at 10 years, with heart failure
being the major cause of death. Extensive myocardial ischemia preoperatively predicted 1-year
but not 10-year survival.
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